Loss of Appetite in Adult Patients: Effectiveness and Safety of an Appetite Stimulating Medication in an Open-Label, Investigator-Initiated Study in India

Table 1

Demographics and patient baseline characteristics (safety population).

Parameter	Overall (N = 50)
Gender, n (%)
Male	33 (66)
Female	17 (34)
Age (years)
Mean (SD)	42.12 (9.41)
Median	43.00
Range	22.00; 53.00
Weight (kg)
Mean (SD)	66.37 (11.91)
Median	68.00
Range	40.00; 94.00
BMI (kg/m^2)
Mean (SD)	24.67 ± 3.81
Median	24.91
Range	14.69; 35.82
Medical history of patients, n (%)
Loss of appetite	50 (100)
Type II diabetes mellitus	22 (44.0)
Essential hypertension	16 (32.0)
Viral fever and hypothyroidism	6 (12.0) each
Vitamin deficiency and allergic bronchitis	5 (10.0) each
Vitamin B12 deficiency	3 (6.0)
Arthritis	2 (4.0)
Acute febrile illness, diabetic foot injury, fever, hyperlipidemia, and vitamin D deficiency	1 (2.0) each

Safety population consisted of all patients who received at least one dose of the study medication. SD, standard deviation.